Bladder Cancer VL

Perioperative Optimization for Patients Undergoing Radical Cystectomy – Sarah Psutka

Details
Ashish Kamat and Sarah Psutka, discuss how to optimize radical cystectomy patients long before the patient even enters the operating room. Dr. Psutka touches on the complications of the procedure, as well as ways that we can try to limit those complications. They also discuss risk stratification and additional testing for radical cystectomy candidates. Biographies: Sarah P. Psutka, MD, MSc, Urolog...

Mucosal Differences in The Bladder - Molly Ingersoll

Details
Ashish Kamat and Molly Ingersoll, discuss mucosal immunity in the bladder with specific reference to gender differences and how that affects biology. Dr. Ingersoll shares how the immune system knows how to kill specific tumor cells, and how those are mechanistically different between sexes. This conversation also addresses the need to form larger collaborative research efforts to really attack the...

Translational Research in Bladder Cancer, A BCAN Young Investigator - Phillip Abbosh

Details
Urologic Oncologist Phillip Abbosh joins Alicia Morgans discussing the importance of the Bladder Cancer Advocacy Network (BCAN) Young Investigator Awards for early-career investigators to join the bladder cancer scientific community and those thinking about getting their projects and their careers off the ground in bladder cancer. Phillip Abbosh a BCAN YI Award recipient in 2018 shares details of...

Bladder Cancer Advocacy Network's (BCAN) Young Investigator Award Program - Elizabeth Plimack

Details
Alicia Morgans is joined by Elizabeth Plimack to discuss the importance of the Bladder Cancer Advocacy Network's (BCAN) Young Investigator Award Program. BCAN is the Bladder Cancer Advocacy Network which started as a small group of urology-based advocates and has grown to "the" organization for bladder cancer advocacy. The Young Investigator Award program strives to grow the science in bladder can...

Financial Toxicity Among Patients with Bladder Cancer - Deborah Kaye

Details
Urologic Oncologist, Deborah Kaye joins Ashish Kamat in a conversation on financial toxicity among bladder cancer patients highlighting the costs of bladder cancer, what is financial toxicity, and lastly, some of the research done on financial toxicity in bladder cancer. Biographies: Deborah Kaye, MD, MS, Urologic Oncologist, Assistant Professor of Surgery, Division of Urology, Duke Cancer Center,...

Bladder Cancer: A Practical Guide - Ashish Kamat & Peter Black

Details
Alicia Morgans is joined by Ashish Kamat and Peter Black to discuss their recent book on bladder cancer, Bladder Cancer: A Practical Guide. This book provides a practical, comprehensive, state-of-the-art review of bladder cancer, and is a valuable resource for anyone with an interest in urothelial tumors. Biographies: Peter Black, MD, Senior Research Scientist, Vancouver Prostate Centre, Professor...

From Athens to Seattle: A Global Conversation on Urologic Care and the Société Internationale d'Urologie - Petros Grivas & Athanasios Papatsoris

Details
In a discussion, Alicia Morgans, Athanasios Papatsoris, and Petros Grivas focus on the Société Internationale d'Urologie (SIU) and its global medical education efforts. Dr. Papatsoris emphasizes the SIU's role as the third-largest urological association, uniting over 10,000 members from 130+ countries, while Dr. Grivas emphasizes its mission to eradicate disparities and educate urologists worldwid...

How Tech Can Minimize Immune-Related Toxicities in Cancer Patients - Pavlos Msaouel

Details
Ashish Kamat hosts Pavlos Msaouel to explore a technology-enabled platform designed to monitor patient-reported outcomes related to immune checkpoint inhibitors. The platform aims to reduce immune-related toxicities without sacrificing antitumor efficacy and uses dynamic electronic symptom alerting rules integrated with laboratory findings for accurate recommendations. Dr. Msaouel emphasizes the p...

Urologists, You’ll Never Walk Alone! - Gianluca Giannarini

Details
Gianluca Giannarini joins Ashish Kamat to discuss a recent publication from European Urology Oncology, an editorial titled, "Urologists, You’ll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non–muscle-invasive Bladder Cancer". Dr. Giannarini discusses the management of patients with high-risk non–muscle-invasive bladder cancer (NMIBC), especially those w...

Systemic Therapies in Advanced Bladder Cancer - Noah Hahn

Details
In this 2021 LUGPA MCE presentation, Noah Hahn presents Systemic Therapies in Advanced Bladder Cancer. He reviews the current data and experiences with immune checkpoint inhibitor therapies, (ICI) targeted therapies, and antibody-drug conjugate (ADC) therapies. Biographies: Noah M. Hahn, MD, Professor of Oncology and Urology, Department of Oncology and Urology, Johns Hopkins University School of M...